GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China

22nd May 2019 Uncategorised 0

GlaxoSmithKline’s shingles vaccine Shingrix has continuously impressed industry watchers with its explosive growth. Now, the company has added another large market to its list: China.

More: GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China
Source: fierce